Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Wednesday, April 22, 2015

REVLIMID (lenalidomide) now available in UK for adult patients with...

REVLIMID now available in UK for adult patients with previously untreated multiple myeloma who are not eligible for transplant Celgene Limited, a wholly owned subsidiary of Celgene Corporation, has announced that REVLIMID is now available for adult patients with previously untreated multiple myeloma who are not eligible for stem cell transplant.
http://ift.tt/1btY2lR

No comments:

Post a Comment

Popular Stem Cell Roundup Posts